Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Familial phenotype differences in PKD11.

N Hateboer1, L P Lazarou, A J Williams

  • 1Institute of Medical Genetics, University Hospital of Wales, Heath Park, Cardiff, United Kingdom. Hateboer@Cardiff.AC.UK

Kidney International
|July 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The psychosocial experiences of women diagnosed with PMOS in Trinidad and Tobago: a qualitative inquiry.

Women & health·2026
Same author

Development of chemical categories for per- and polyfluoroalkyl substances (PFAS) and the proof-of-concept approach to the identification of potential candidates for tiered toxicological testing and human health assessment.

Computational toxicology (Amsterdam, Netherlands)·2025
Same author

Satellite-based vertical land motion for infrastructure monitoring: a prototype roadmap in Greater Houston, Texas.

Scientific reports·2025
Same author

Feasibility study of the implementation of health promoting processes in a secondary school and ways to capture its impact on adolescent lifestyle choices.

Public health in practice (Oxford, England)·2025
Same author

Comparison of tetramethylammonium hydroxide (TMAH), trimethylsulfonium hydroxide (TMSH), and trimethylphenylammonium hydroxide (TMPAH) thermochemolysis for in situ space analysis of organic molecules in planetary environments.

Talanta·2023
Same author

Effects of COVID-19 on Vaccine-Preventable Disease Surveillance Systems in the World Health Organization African Region, 2020.

Emerging infectious diseases·2022
Same journal

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026
Same journal

Crystal-Storing Histiocytosis Causing Severe AKI.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
See all related articles

Differences in clinical severity exist between families with autosomal dominant polycystic kidney disease (ADPKD) caused by PKD1 gene mutations. These familial phenotype variations suggest diverse underlying genetic causes for ADPKD.

Area of Science:

  • Genetics and Molecular Biology
  • Nephrology
  • Clinical Genetics

Background:

  • Mutations in the PKD1 gene are the primary cause of autosomal dominant polycystic kidney disease (ADPKD), the most common and severe form.
  • While intrafamilial variability in ADPKD severity is recognized, inter-familial differences in clinical presentation remain uncertain.

Purpose of the Study:

  • To investigate whether distinct clinical severity differences exist among different families affected by PKD1-linked ADPKD.
  • To explore the association between unique disease-associated haplotypes and observed phenotype variations across families.

Main Methods:

  • Study included ten large South Wales ADPKD families with at least 12 affected members each.
  • Clinical data, including survival and ADPKD-associated complications, were collected from affected individuals.

Related Experiment Videos

  • Linkage and haplotype analysis using microsatellite markers near the PKD1 gene were performed; survival data analyzed using Kaplan-Meier and log-rank tests.

    • Main Results:

    • Haplotype analysis confirmed PKD1 linkage in all families, with each family exhibiting a unique disease-associated haplotype.
    • Significant inter-familial differences were observed in overall survival (P=0.0004), renal survival (P=0.0001), hypertension prevalence (P=0.013), and hernia occurrence (P=0.048).
    • Hypertension was associated with significantly worse overall and renal survival.

    Conclusions:

    • Phenotype differences are confirmed to exist between different PKD1-linked ADPKD families.
    • These variations are likely attributed to a heterogeneous spectrum of underlying PKD1 mutations, indicated by unique disease-associated haplotypes.